STOCK TITAN

Pelican Acquisition II closes $86.25M Nasdaq IPO

(Very High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Pelican Acquisition II Corporation (PLCI) reported that it completed its initial public offering of 8,625,000 units, including the full exercise of the underwriters’ over-allotment option of 1,125,000 units, at $10.00 per unit on July 27, 2026, for total gross proceeds of $86,250,000. Each unit consists of one ordinary share and one right, with each right entitling the holder to receive one-tenth (1/10) of an ordinary share upon consummation of an initial business combination. The units trade on Nasdaq under the symbol PLCIU, with the ordinary shares and rights expected to trade separately as PLCI and PLCIR.

Simultaneously, the company completed a private placement of 386,500 Private Units at $10.00 per unit, generating additional gross proceeds of $3,865,000, purchased by Pelican II Capital Solutions Limited and EarlyBirdCapital, Inc. and/or its designees, without underwriting discounts or commissions. Pelican appointed three independent directors, formed its audit and compensation committees (with Sean Michael Deegan designated as an audit committee financial expert), and adopted Amended and Restated Memorandum and Articles of Association effective with the registration statement.

Positive

  • Completion of IPO raising $86,250,000 in gross proceeds, including full over-allotment exercise.
  • Additional $3,865,000 raised via private placement of 386,500 units with no underwriting discounts or commissions.
  • Nasdaq listing of units under PLCIU, with ordinary shares and rights expected to trade as PLCI and PLCIR.
  • Board strengthened with three independent directors and establishment of audit and compensation committees, including an audit committee financial expert.

Negative

  • None.

Filing Explained

Gross proceeds were disclosed, not net proceeds; the private-unit issuance also reduces existing holders’ percentage ownership absent offsetting changes.

The July 27 IPO closing is complete, but the reported $86,250,000 is gross proceeds before underwriting discounts and estimated offering expenses; the filing therefore does not state that amount as net proceeds.

The $3,865,000 private placement issued 386,500 units that are identical to the IPO units except for transfer restrictions and registration rights, giving those securities different resale mechanics.

Because the private units include additional ordinary shares, the disclosed issuance reduces existing holders’ percentage ownership absent offsetting changes; the filing does not size that ownership effect.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
IPO units 8,625,000 units Initial public offering units issued, including full over-allotment, at closing on July 27, 2026
IPO gross proceeds $86,250,000 Total gross proceeds from IPO at $10.00 per unit
Over-allotment units 1,125,000 units Additional units issued pursuant to underwriters’ full over-allotment option
Original IPO sizing 7,500,000 units Units priced on July 23, 2026 at $10.00 per unit before over-allotment
Private Placement Units 386,500 units Private Units sold concurrently with IPO closing at $10.00 per unit
Private Placement proceeds $3,865,000 Aggregate gross proceeds from sale of 386,500 Private Units
Unit price $10.00 per unit Price for both IPO Units and Private Units
Independent directors appointed 3 directors Daniel M. McCabe, Becky Fallon, and Sean Michael Deegan appointed effective July 23, 2026
over-allotment option financial
"including 1,125,000 Units issued pursuant to the full exercise by the underwriters of their over-allotment option"
An over-allotment option is a special agreement that allows underwriters to sell more shares than initially planned if demand is high. Think of it like a retailer offering extra units of a popular product to meet additional customer interest. This option helps ensure the full sale is completed and can also give investors extra shares if they want more.
blank check company financial
"Pelican Acquisition II Corporation is a blank check company formed for the purpose"
A blank check company is a publicly listed shell that raises money from investors before naming a specific business to buy or merge with, similar to handing a cashier a signed check and asking them to fill in the payee later. It matters to investors because it offers a faster, often cheaper path for private firms to become public, but carries extra risk since returns depend on the organizers’ ability to find a good deal and on limited information about the future business.
Rights Agreement financial
"Rights Agreement, dated July 23, 2026, by and between the Company and Continental"
A rights agreement is a contract that grants existing shareholders special rights—commonly the option to buy additional shares at a set price or to trigger protections if a takeover is attempted. Think of it like a neighborhood watch rule that lets current homeowners buy extra lots or lock the gate when an outsider tries to take over the block; it matters to investors because it can dilute or protect share value and influence takeover outcomes.
Investment Management Trust Agreement financial
"Investment Management Trust Agreement, dated July 24, 2026, by and between the Company"
A written contract that names who will run and make investment decisions for a trust’s assets, spells out their authority, duties, fees and how performance and risks will be handled. It matters to investors because it defines who is responsible for growing and protecting the money—like hiring a caretaker with a clear job description—and sets the rules and safeguards that affect returns, costs and how disputes or withdrawals are resolved.
Registration Rights Agreement financial
"Registration Rights Agreement, dated July 23, 2026, by and between the Company and the Sponsor"
A registration rights agreement is a contract that gives investors the option to have their ownership stakes officially registered with the government, making it easier to sell their shares later. This agreement matters because it provides investors with a clearer path to cash out their investments if they choose, offering more liquidity and confidence in their ability to sell their holdings when desired.
audit committee financial expert regulatory
"Sean Michael Deegan qualifies as an “audit committee financial expert” as that term is defined"
A person on a company’s board who has deep knowledge of accounting, financial reporting and auditing, able to understand and question the books, controls and audit work like a trained mechanic inspecting an engine. Investors care because that expertise helps spot errors, weaknesses or misleading statements early, improving the likelihood that financial reports are accurate and reducing the risk of surprises that can hurt a company’s value.

FAQ

What did Pelican Acquisition II Corporation (PLCI) announce in this 8-K?

Pelican Acquisition II Corporation reported the closing of its initial public offering of 8,625,000 units at $10.00 per unit for gross proceeds of $86,250,000, a concurrent private placement of 386,500 units for $3,865,000, new director appointments, and adoption of amended charter documents.

How large was PLCI’s IPO and what are the unit terms?

The IPO consisted of 8,625,000 units at $10.00 per unit, including the underwriters’ full over-allotment of 1,125,000 units, for gross proceeds of $86,250,000. Each unit has one ordinary share and one right to receive one-tenth (1/10) of an ordinary share upon a business combination.

What private placement did PLCI complete alongside the IPO?

Simultaneously with the IPO closing, Pelican Acquisition II Corporation completed a private placement of 386,500 Private Units at $10.00 per unit, raising $3,865,000 in gross proceeds. The sponsor bought 311,500 units and EarlyBirdCapital, Inc. and/or its designees bought 75,000 units.

Where are PLCI’s securities listed and under what symbols?

The units are listed on The Nasdaq Capital Market under the symbol PLCIU. Once the securities trade separately, the ordinary shares are expected to be listed as PLCI and the rights as PLCIR, each on Nasdaq.

What governance changes did PLCI disclose in connection with the IPO?

Effective July 23, 2026, Pelican Acquisition II Corporation added Daniel M. McCabe, Becky Fallon, and Sean Michael Deegan as independent directors, formed audit and compensation committees, named Deegan as audit committee financial expert and chair of the audit committee, and Fallon as chair of the compensation committee.

What corporate charter actions did PLCI take around the IPO?

On July 23, 2026, Pelican Acquisition II Corporation adopted its Amended and Restated Memorandum and Articles of Association, which became effective upon effectiveness of its registration statement, and filed these as Exhibit 3.1.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false --02-28 0002122392 0002122392 2026-07-29 2026-07-29 0002122392 cik0002122392:UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember 2026-07-29 2026-07-29 0002122392 cik0002122392:OrdinaryShares0.0001ParValueMember 2026-07-29 2026-07-29 0002122392 cik0002122392:RightsEachExchangeableForOnetenth110OrdinaryShareMember 2026-07-29 2026-07-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 29, 2026

 

Pelican Acquisition II Corporation

(Exact name of registrant as specified in its charter)

 

Cayman Islands   001-42717   N/A
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

1185 Avenue of the Americas, 3rd Fl.
New York
, NY
  10036
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: Telephone: (212) 612-1400

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of exchange on which registered
Units, each consisting of one ordinary share and one right   PLCIU   Nasdaq Stock Market LLC
Ordinary Shares, $0.0001 par value   PLCI   Nasdaq Stock Market LLC
Rights, each exchangeable for one-tenth (1/10) ordinary share   PLCIR   Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On July 27, 2026, Pelican Acquisition II Corporation (the “Company”) consummated its initial public offering (the “IPO”) of 8,625,000 units (the “Units”), including 1,125,000 Units issued pursuant to the full exercise by the underwriters of their over-allotment option in connection with the closing of the IPO. Each Unit consists of one ordinary share of the Company, par value $0.0001 per share (the “Ordinary Shares”), one right to receive one-tenth (1/10) of one Ordinary Share upon the consummation of the Company’s initial business combination. The Units were sold at an offering price of $10.00 per Unit, generating total gross proceeds of $86,250,000.

 

EarlyBirdCapital Inc. acted as the sole book-running manager in connection with the offering pursuant to the Underwriting Agreement dated July 23, 2026.

 

In connection therewith and the closing of the IPO, the Company entered into the following agreements, the forms of which were previously filed as exhibits to the Company’s registration statement on Form S-1, as amended (File No. 333-296688), originally filed with the U.S. Securities and Exchange Commission on June 11, 2026 and declared effective on July 23, 2026 (the “Registration Statement”):

 

  Underwriting Agreement, dated July 23, 2026, by and between the Company and EarlyBirdCapital Inc., as sole book-running manager for the offering, a copy of which is filed as Exhibit 1.1 hereto and incorporated herein by reference;
     
  Rights Agreement, dated July 23, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as rights agent, a copy of which is filed as Exhibit 4.4 hereto and incorporated herein by reference;
     
  Letter Agreement, dated July 23, 2026, by and among the Company, its officers and directors, and Pelican II Capital Solutions Limited (the “Sponsor”), a copy of which is filed as Exhibit 10.1 hereto and incorporated herein by reference;
     
  Investment Management Trust Agreement, dated July 24, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee, a copy of which is filed as Exhibit 10.2 hereto and incorporated herein by reference;
     
  Registration Rights Agreement, dated July 23, 2026, by and between the Company and the Sponsor, a copy of which is filed as Exhibit 10.3 hereto and incorporated herein by reference;
     
  Private Placement Units Purchase Agreement, dated July 23, 2026, by and between the Company and the Sponsor, a copy of which is filed as Exhibit 10.8 hereto and incorporated herein by reference; and
     
  Administrative Services Agreement, dated March 13, 2026, by and between the Company and the Sponsor, a copy of which is filed as Exhibit 10.9 hereto and incorporated herein by reference;
     
  Share Escrow Agreement, dated as of July 24, 2026, by and among Pelican Acquisition II Corporation, Pelican II Capital Solutions Limited, the shareholders party thereto and Continental Stock Transfer & Trust Company, as Escrow Agent, pursuant to which the Founder Shares were deposited into escrow, a copy of which is filed as Exhibit 10.10 hereto and incorporated herein by reference.
     
  Indemnification Agreements, each dated July 23, 2026, by and between the Company and each of its directors and officers, including Robert Labbe, Daniel M. McCabe, Becky Fallon, and Sean Michael Deegan, copies of which are filed as Exhibits 99.3, 99.4, 99.5 and 99.6 hereto and incorporated herein by reference.

 

1

 

 

Item 3.02 Unregistered Sales of Equity Securities.

 

Simultaneously with the consummation of the IPO, the Company consummated a private placement (the “Private Placement”) of an aggregate of 386,500 Units (the “Private Units”) at a price of $10.00 per Private Unit, generating aggregate gross proceeds of $3,865,000. Of the Private Units, 311,500 units were purchased by Pelican II Capital Solutions Limited, the Company’s sponsor, and 75,000 units were purchased by EarlyBirdCapital, Inc. and/or its designees. The Private Units are identical to the Units sold in the IPO, except that the Private Units are subject to certain transfer restrictions and registration rights as described in the Registration Statement. No underwriting discounts or commissions were paid with respect to such sale.

 

The issuance of the Private Units was made pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Effective July 23, 2026, in connection with the effectiveness of the Company’s Registration Statement, Daniel M. McCabe, Becky Fallon, and Sean Michael Deegan, became members of the board of directors (the “Board”) of the Company.

 

The Board has determined that each of Daniel M. McCabe, Becky Fallon, and Sean Michael Deegan qualify as an independent director under the applicable listing standards of the Nasdaq Capital Market (“Nasdaq”) and under the rules and regulations of the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

 

Daniel M. McCabe, Becky Fallon, and Sean Michael Deegan serve as members of the Company’s audit committee and compensation committee. Sean Michael Deegan serves as chairperson of the audit committee and Becky Fallon serves as chairperson of the compensation committee. Sean Michael Deegan qualifies as an “audit committee financial expert” as that term is defined in Item 407(d)(5) of Regulation S-K under the Exchange Act.

 

The directors will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable business combinations.

 

Other than the foregoing, none of the directors is party to any arrangement or understanding with any person pursuant to which they were appointed as directors, nor is any director party to any transaction required to be disclosed under Item 404(a) of Regulation S-K involving the Company.

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws.

 

On July 23, 2026, the Company adopted its Amended and Restated Memorandum and Articles of Association, which became effective upon the effectiveness of the Company’s Registration Statement.

 

A copy of the Amended and Restated Memorandum and Articles of Association is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

2

 

 

Item 9.01 Financial Statements and Exhibits.

 

  (d) Exhibits. The following exhibits are filed with this Form 8-K:

 

Exhibit No.   Description
1.1   Underwriting Agreement, dated July 23, 2026, by and between the Company and EarlyBirdCapital Inc., as sole book-running manager for the offering.
     
3.1   Second Amended and Restated Memorandum and Articles of Association
     
4.4   Rights Agreement, dated July 24, 2026, by and between the Company and Continental Stock Transfer & Trust Company
     
10.1   Letter Agreement, dated July 23, 2026, by and among the Company, its officers and directors, and Pelican II Capital Solutions Limited
     
10.2   Investment Management Trust Agreement, dated July  24, 2026, by and between the Company and Continental Stock Transfer & Trust Company
     
10.3   Registration Rights Agreement, dated July 23, 2026, by and between the Company and Pelican II Capital Solutions Limited
     
10.7   Private Placement Units Purchase Agreement, dated July 23, 2026, by and between the Company and the Sponsor
     
10.9   Administrative Services Agreement, dated March 13, 2026, by and between the Company and the Sponsor
     
10.10   Share Escrow Agreement, dated as of July 24, 2026, by and among Pelican Acquisition II Corporation, Pelican II Capital Solutions Limited, the shareholders party thereto and Continental Stock Transfer & Trust Company, as Escrow Agent.
     
10.11   Indemnification Agreement, dated July 23, 2026, by and between Pelican Acquisition II Corporation and Robert Labbe.
     
10.12   Indemnification Agreement, dated July 23, 2026, by and between Pelican Acquisition II Corporation and Daniel M. McCabe.
     
10.13   Indemnification Agreement, dated July 23, 2026, by and between Pelican Acquisition II Corporation and Becky Fallon.
     
10.14   Indemnification Agreement, dated July 23, 2026, by and between Pelican Acquisition II Corporation and Sean Michael Deegan.
     
99.1   Press Release Announcing Pricing of IPO.
     
99.2   Press Release Announcing Closing of IPO and full exercise of Over-allotment
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

3

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Pelican Acquisition II Corporation
     
Date: July 31, 2026 By: /s/ Robert Labbe
  Name: Robert Labbe
  Title:

Chief Executive Officer and Chairman

(Principal Executive Officer, Principal Accounting Officer, and Principal Financial Officer)

 

4

 

Exhibit 99.1

 

Pelican Acquisition II Corporation Announces Pricing of $75,000,000

Initial Public Offering

 

New York, NY, July 23, 2026 – Pelican Acquisition II Corporation (NASDAQ: PLCIU) (the “Company”), a Cayman Islands exempted company, announced that it priced its initial public offering of 7,500,000 units at $10.00 per unit on July 23, 2026. The units will be listed on the Nasdaq Capital Market (“NASDAQ”) and are expected to trade under the ticker symbol “PLCIU” beginning on July 24, 2026. Each unit consists of one ordinary share of the Company and one right, with each right entitling the holder thereof to receive one-tenth (1/10) of one ordinary share upon the consummation of an initial business combination. Once the securities comprising the units begin separate trading, the ordinary shares and rights are expected to be listed on NASDAQ under the symbols “PLCI” and “PLCIR”, respectively. The offering is expected to close on July 27, 2026, subject to customary closing conditions.

 

EarlyBirdCapital, Inc. is acting as sole book-running manager in the offering. EarlyBirdCapital has been granted a 45-day option to purchase up to an additional 1,125,000 units offered by the Company at the initial public offering price to cover over-allotments, if any.

 

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on July 23, 2026. The offering is being made only by means of a prospectus. Copies of the prospectus may be obtained, when available, by contacting EarlyBirdCapital, Inc., 366 Madison Avenue, 8th floor, New York, NY 10017, Attention: Syndicate Department, or by calling 212-661-0200. Copies of the registration statement can be accessed through the SEC’s website at www.sec.gov.

 

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

 

About Pelican Acquisition II Corporation

 

Pelican Acquisition II Corporation is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company’s efforts to identify a prospective target business will not be limited to a particular industry or geographic region.

 

Forward-Looking Statements

 

This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements, including with respect to the initial public offering, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. No assurance can be given that the initial public offering will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as described in the offering prospectus. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

 

Contact

 

Robert Labbe

Chief Executive Officer

Email: admin@pelicanacq.com

Tel: (212) 612-1400

 

 

 

Exhibit 99.2

 

Pelican Acquisition II Corporation Announces Closing of
Initial Public Offering

 

NEW YORK, NY, July 28, 2026 (GLOBE NEWSWIRE) – Pelican Acquisition II Corporation (Nasdaq: PLCIU, the “Company”) announced today that it has closed on July 27, 2026 its initial public offering of 8,625,000 units at $10.00 per unit, including the 1,125,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option, resulting in aggregate gross proceeds of $86,250,000, before deducting underwriting discounts and estimated offering expenses.

 

Each unit consists of one ordinary share of the Company and one right, with each right entitling the holder thereof to receive one-tenth (1/10) of one ordinary share upon the consummation of an initial business combination. The units are listed on The Nasdaq Capital Market (“Nasdaq”) and began trading under the ticker symbol “PLCIU” on July 24, 2026. Once the securities comprising the units begin separate trading, the ordinary shares and rights are expected to be listed on Nasdaq under the symbols “PLCI,” and “PLCIR,” respectively.

 

EarlyBirdCapital, Inc. acted as sole book-running manager for this offering.

 

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on July 23, 2026. The offering was made only by means of a prospectus. Copies of the prospectus may be obtained, by contacting EarlyBirdCapital, Inc., 366 Madison Avenue, New York, NY 10017, Attention: Syndicate Department, or by calling 212-661-0200. Copies of the registration statement can be accessed through the SEC’s website at www.sec.gov.

 

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

 

About Pelican Acquisition II Corporation

 

Pelican Acquisition II Corporation is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company’s efforts to identify a prospective target business will not be limited to a particular industry or geographic region.

 

Forward-Looking Statements

 

This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

 

Contact

Robert Labbe

Chief Executive Officer

Email: admin@pelicanacq.com

Tel: (212) 612-1400

 

 

 

Filing Exhibits & Attachments

22 documents